Stockreport

ImmunityBio, Inc. Announces Pricing of Public Offering of Common Stock

ImmunityBio, Inc.  (IBRX) 
PDF CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the pricing of its previously announced unde [Read more]